. 2020 Apr 24;22(12):1851–1861. doi: 10.1093/neuonc/noaa107
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Fig. 2.
(A) PFS and (B) OS for all patients according to treatment arm.